Comment: Fulvestrant improves survival over anastrozole for patients with advanced breast cancer

Comment: Multigene test can predict risk of disease recurrence for women with ductal carcinoma in situ

Comment: BOLERO-1 reports HER2-positive breast cancer latest PFS data

New IMRT techniques could be tissue-sparing and promote dosage conformity in breast cancer

Tamoxifen lowered breast cancer rates among high-risk women

Reducing fat intake reduces death rates in some breast cancer patients

Recurrence risk could be predicted by a multigene test in ductal carcinoma breast cancer

Breast cancer in men and women has different biological characteristics and outcomes

PD-1 inhibitor pembrolizumab shows promising clinical activity for triple-negative breast cancer

Adding ultrasound to routine mammography improves cancer detection in dense breasts

High tumour immune cell levels may help screen HER2-positive breast cancer patients for chemo

CLL at ASH 2014: Expert discussion